
|Articles|September 1, 2005
Grand Rounds: Will active management of obstetric risk lower C/S rates?
Can a radical approach that's counter to conventional wisdom cut climbing cesarean rates by inducing labor in patients with risk—before their risk becomes an indication for C/S? It's certainly controversial—but it just might be right!
Advertisement
Newsletter
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
DARE to PLAY sildenafil cream becomes commercially available for women in select states
2
High costs and transfusions linked to acute heavy menstrual bleeding
3
Edward Hook, MD, discusses FDA approval of oral zoliflodacin for uncomplicated gonorrhea
4
FDA approves zoliflodacin (Nuzolvence) for uncomplicated gonorrhea
5










